Investview Q3 net revenue drops 72.5% on continued contraction in its European marketing network
INVU•Investview’s Q3 net revenue fell 72.5% year over year to $2.2 million. It reported $9 million in net income, mainly from selling an equity investment, and said it targets initial Opencash commercial operations by the end of Q2 2027.
1. Revenue and income
Investview’s Q3 net revenue fell 72.5% year over year to $2.2 million. The company reported $9 million in net income, mainly from the sale of an equity investment, and repurchased 2 million shares under its buyback program during the quarter.
2. Business drivers and outlook
The revenue decline was mainly due to continued contraction in Investview’s European marketing network after a regulatory decision in Poland. Renu Laboratories’ revenue fell as management discontinued or restructured higher-volume, lower-margin customer arrangements. Investview continued spending to develop Opencash Securities, which remains pre-commercial and pre-revenue, and targets initial commercial operations by the end of Q2 2027, subject to regulatory and operational readiness.
